These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21604997)

  • 1. Domains of apoE4 required for the biogenesis of apoE-containing HDL.
    Vezeridis AM; Chroni A; Zannis VI
    Ann Med; 2011 Jun; 43(4):302-11. PubMed ID: 21604997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aminoterminal 1-185 domain of human apolipoprotein E suffices for the de novo biogenesis of apoE-containing HDL-like particles in apoA-I deficient mice.
    Petropoulou PA; Gantz DL; Wang Y; Rensen PC; Kypreos KE
    Atherosclerosis; 2011 Nov; 219(1):116-23. PubMed ID: 21802082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models.
    Zannis VI; Koukos G; Drosatos K; Vezeridis A; Zanni EE; Kypreos KE; Chroni A
    Ann Med; 2008; 40 Suppl 1():14-28. PubMed ID: 18246469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.
    Drosatos K; Kypreos KE; Zannis VI
    Biochemistry; 2007 Aug; 46(33):9645-53. PubMed ID: 17655277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
    Zannis VI; Chroni A; Krieger M
    J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.
    Chroni A; Koukos G; Duka A; Zannis VI
    Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.
    Zannis VI; Chroni A; Kypreos KE; Kan HY; Cesar TB; Zanni EE; Kardassis D
    Curr Opin Lipidol; 2004 Apr; 15(2):151-66. PubMed ID: 15017358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
    Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
    Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.
    Duka A; Fotakis P; Georgiadou D; Kateifides A; Tzavlaki K; von Eckardstein L; Stratikos E; Kardassis D; Zannis VI
    J Lipid Res; 2013 Jan; 54(1):107-15. PubMed ID: 23132909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
    Rye KA; Bright R; Psaltis M; Barter PJ
    J Lipid Res; 2006 May; 47(5):1025-36. PubMed ID: 16452453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE.
    Peng D; Song C; Reardon CA; Liao S; Getz GS
    J Neurochem; 2003 Sep; 86(6):1391-402. PubMed ID: 12950448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
    Chen X; Burton C; Song X; McNamara L; Langella A; Cianetti S; Chang CH; Wang J
    Int J Biol Sci; 2009 Jul; 5(5):489-99. PubMed ID: 19680471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins.
    Hirsch-Reinshagen V; Donkin J; Stukas S; Chan J; Wilkinson A; Fan J; Parks JS; Kuivenhoven JA; Lütjohann D; Pritchard H; Wellington CL
    J Lipid Res; 2009 May; 50(5):885-93. PubMed ID: 19065001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
    Settasatian N; Barter PJ; Rye KA
    J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
    Fotakis P; Vezeridis A; Dafnis I; Chroni A; Kardassis D; Zannis VI
    J Lipid Res; 2014 Jul; 55(7):1310-23. PubMed ID: 24776540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
    Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
    J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.